Advanced Biomed Inc. ADVB
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 199.06% | 64.67% | -45.67% | -45.67% | 13.32% |
| Total Depreciation and Amortization | 34.56% | -58.67% | -53.03% | -53.03% | -144.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 78.23% | -100.00% | -- | -- | -- |
| Change in Net Operating Assets | -113.79% | 105.63% | -303.07% | -303.07% | 1,567.93% |
| Cash from Operations | 62.22% | 92.97% | -1,954.88% | -1,954.88% | -224.51% |
| Capital Expenditure | 38.26% | 40.91% | 91.00% | 91.00% | 121.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 339.12% | -- | -- | -- | -- |
| Cash from Investing | -12,288.56% | 40.91% | 91.00% | 91.00% | 62.29% |
| Total Debt Issued | 291.61% | -99.11% | 12.07% | 12.07% | -219.56% |
| Total Debt Repaid | -- | 1,527.27% | -- | -- | -- |
| Issuance of Common Stock | -- | -95.57% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -100.00% | -- | -- | -98.13% |
| Cash from Financing | 222.38% | -95.45% | 14.01% | 14.01% | -336.63% |
| Foreign Exchange rate Adjustments | -274.90% | -173.55% | 72.78% | 72.78% | -67.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.50% | -100.08% | -734.36% | -734.36% | -3,993.72% |